Precision BioSciences, Inc.
DTIL
$7.43
$0.131.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 37,272.41% | 5,261.13% | -97.74% | -99.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 37,272.41% | 5,261.13% | -97.74% | -99.96% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 37,272.41% | 5,261.13% | -97.74% | -99.96% |
| SG&A Expenses | -25.86% | -20.46% | 0.42% | -15.79% | 7.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.49% | -10.06% | -14.86% | -5.36% | -14.98% |
| Operating Income | 12.41% | 58.96% | 150.34% | 2.86% | -190.60% |
| Income Before Tax | -38.83% | 10.33% | 208.47% | -32.55% | -171.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -38.83% | 10.33% | 208.47% | -32.55% | -171.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.83% | 10.33% | 213.46% | -32.55% | -171.82% |
| EBIT | 12.41% | 58.96% | 150.34% | 2.86% | -190.60% |
| EBITDA | 12.05% | 59.59% | 152.69% | 1.18% | -185.19% |
| EPS Basic | 40.69% | 66.18% | 147.64% | 18.27% | -145.29% |
| Normalized Basic EPS | 34.16% | 71.64% | 148.87% | 21.01% | -140.27% |
| EPS Diluted | 40.71% | 66.11% | 147.31% | 18.27% | -145.61% |
| Normalized Diluted EPS | 34.16% | 71.64% | 148.57% | 21.01% | -140.53% |
| Average Basic Shares Outstanding | 134.07% | 165.11% | 138.16% | 62.18% | 58.56% |
| Average Diluted Shares Outstanding | 134.07% | 165.11% | 139.67% | 62.18% | 57.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |